Advances in the Biology of JC Virus and Induction of Progressive Multifocal Leukoencephalopathy

References

• Agostini HT, Jobes DV, Stoner GL (2001). Molecular evo-lution and epidemiology of JC virus. In: Human poly-omaviruses: molecular and clinical perspectives. Khalili K, Stoner GL (eds). New York: John Wiley and Sons, pp 491–526.
   Google Scholar
• Aksamit AJ (2001). Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabi-noside. NeuroVirol 7: 386–390.
   PubMed Web of Science ®Google Scholar
• Aksamit AJ, Major EO, et al (1987). Diagnosis of progres-sive multifocal leukoencephalopathy by brain biopsy with biotin labeled DNA:DNA in situ hybridization. J Neuropathol Exp Neurol 46: 556–566.
   PubMed Web of Science ®Google Scholar
• Amemiya K, Traub R, et al (1989). Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. J Biol Chem 264: 7025–7032.
   PubMedGoogle Scholar
• Amemiya K, Traub R, et al (1992). Adjacent nuclear factor-1 and activator protein binding sites in the en-hancer of the neurotropic JC virus. A common charac-teristic of many brain-specific genes. J Biol Chem 267: 14204–14211.
   Google Scholar
• Andrei G, Snoeck R, et al (1997). Activities of various com-pounds against murine and primate polyomaviruses. Antimicrobial Agents Chemother 41: 587–593.
   PubMed Web of Science ®Google Scholar
• Antinori A, A=assari A, et al (2001). Epidemiology and prognosis of AIDS-associated progressive multifo-cal leukoencephalopathy in the HAART era. J NeuroVi-rol 7: 323–328.
   PubMed Web of Science ®Google Scholar
• Ariza A, von Uexkull-Guldeband C, et al (1996). Accumu-lation of wild-type p53 protein in progressive multifo-cal leukoencephalopathy: a flow of cytometry and DNA sequencing study. J Neuropathol Exp Neurol 55: 144–149.
   Google Scholar
• Astrom KE, Mancall EL, et al (1958). Progressive multifo-cal leukoencephalopathy. Brain 81: 93–127.
   PubMed Web of Science ®Google Scholar
• Atwood WJ (2001). A combination of low-dose chlorpro-mazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: implica-tions for prophylactic and therapeutic treatment of pro-gressive multifocal leukencephalopathy. J NeuroVirol 7: 307–310.
   PubMed Web of Science ®Google Scholar
• Berger JR, Concha M (1995). Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J NeuroVirol 1: 5–18.
   PubMed Web of Science ®Google Scholar
• Bofill-Mas S, Formiga-Cruz M, et al (2001). Potential trans-mission of human polyomaviruses through the gastroin-testinal tract after exposure to virions or viral DNA. J Virol 75: 10290–10299.
   Google Scholar
• Caldarelli-Stefano R, Boldorini R, et al (2000). JC virus in human glial-derived tumors. Hum Pathol 31: 394–395.
   PubMed Web of Science ®Google Scholar
• Chang D, Fung CY, et al (1997). Self-assembly of the JC virus major capsid protein, VP1, expressed in insect cells. J Gen Virol 78 (Pt 6): 1435–1439.
   PubMed Web of Science ®Google Scholar
• Chen NN, Khalili K (1995). Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur alpha in glial cells. J Virol 69: 5843–5848.
   PubMedGoogle Scholar
• Chowdhury M, Kundu M, et al (1993). GA/GC-rich sequence confers Tat responsiveness to human neu-rotropic virus promoter, JCVL, in cells derived from cen-tral nervous system. Oncogene 8: 887–892.
   PubMed Web of Science ®Google Scholar
• Cinque P, Koralnik IJ, et al (2003). The evolving face of HIV-related progressive multifocal leukoencephalopa-thy: Defining a consensus terminology. J NeuroVirol 9(s1): (In press).
   Google Scholar
• Cinque P, Scarpellini P, et al (1997). Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain re-action. AIDS 11: 1–17.
   PubMed Web of Science ®Google Scholar
• Clifford DB, Yiannoutsos C, et al (1999). HAART im-proves prognosis in HIV-associated progressive multi-focal leukoencephalopathy. Neurology 52: 623–625.
   PubMed Web of Science ®Google Scholar
• Daniel AM, Swenson JJ, et al (1996). Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology 216: 90–101.
   PubMed Web of Science ®Google Scholar
• Darbinyan A, Darbinian N, et al (2002). Evidence for dys-regulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene 21: 5574–5581.
   PubMed Web of Science ®Google Scholar
• De Luca A, Fantoni M, et al (1999). Response to cido-fovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 52: 891–892.
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola ML, et al (2001). Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study. J NeuroVirol 7: 364–368.
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola ML, et al (2000a). Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoen-cephalopathy. AIDS 14: F117–F121.
   Google Scholar
• De Luca A, Giancola ML, et al (2000b). The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoen-cephalopathy. j Infect Dis 182: 1077–1083.
   PubMed Web of Science ®Google Scholar
• Del Valle L, Gordon J, et al (2001). Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous sys-tem. Cancer Res 61: 4287–4293.
   PubMed Web of Science ®Google Scholar
• Dorries K, Vogel E, et al (1994). Infection of human poly-omaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198: 59–70.
   PubMed Web of Science ®Google Scholar
• Frisque RJ (2001). Structure and function of JC virus T' proteins. J NeuroVirol 7: 293–297.
   PubMed Web of Science ®Google Scholar
• Frisque RJ, Bream GL, et al (1984). Human polyomavirus JC virus genome. J Virol 51: 458–469.
   PubMed Web of Science ®Google Scholar
• Frisque RJ, White FA (1992). The molecular biology of JC virus, causative agent of progressive multifocal leukoen-cephalopathy. In: Molecular neurovirology, Roos R (ed.). pp. 25–158, Humana Press, New Jersey.
   Google Scholar
• Garcia De Viedma D, Diaz Infantes M, et al (2002). JC virus load in progressive multifocal leukoencephalopa-thy: analysis of the correlation between the viral bur-den in cerebrospinal fluid, patient survival, and the volume of neurological lesions. Clin Infect Dis 34: 1568–1575.
   Google Scholar
• Gasnault J, Kousignian P, et al (2001). Cidofovir in AIDS-associated progressive multifocal leukoencephalopa-thy: a monocenter observational study with clinical and JC virus load monitoring. I NeuroVirol 7: 375–381.
   PubMed Web of Science ®Google Scholar
• Gasnault J, Taoufik Y, eta] (1999). Prolonged survival with-out neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. J NeuroVirol 5: 421–429.
   PubMed Web of Science ®Google Scholar
• Geschwind MD, Skolasky RI, et al (2001). The relative con-tributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS. J NeuroVirol 7: 353–357.
   PubMed Web of Science ®Google Scholar
• Giudici B, Vaz B, et al (2000). Highly active antiretroviral therapy and progressive multifocal leukoencephalopa-thy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30: 95–99.
   PubMed Web of Science ®Google Scholar
• Goldmann C, Petry H, et al (1999). Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies. J Virol 73: 4465–4469.
   PubMed Web of Science ®Google Scholar
• Goldmann C, Stolte N, et al (2000). Packaging of small molecules into VP1-virus-like particles of the human polyomavirus JC virus. J Virol Methods 90: 85–90.
   PubMed Web of Science ®Google Scholar
• Greenlee JE (1989). In: Progressive multifocal leukoen-cephalopathy, Remington LS, Schwartz MN (eds.). p. 140, Blackwell Scientific, Boston.
   Google Scholar
• Greenlee JE, Keeney PM (1986). I=unoenzymatic la-belling of JC papovavirus T antigen in brains of patients with progressive multifocal leukoencephalopathy. Acta Neuropathol (Berl) 71: 150–153.
   Google Scholar
• Hall CD, Dafni U, et al (1998). Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. NEng/JMed 338: 1345–1351.
   Google Scholar
• Hamilton RS, Gravell M, et al (2000). Comparison of anti-body titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J Clin Microbic)] 38: 105–109.
   PubMed Web of Science ®Google Scholar
• Henson J, Saffer J, et al (1992). The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Ann Neurol 32: 72–77.
   PubMedGoogle Scholar
• Hou J, Major EO (1998). The efficacy of nucleoside analogs against JC virus multiplication in a persistently in-fected human fetal brain cell line. J NeuroVirol 4: 451–456.
   PubMed Web of Science ®Google Scholar
• Houff SA, Major EO, et al (1988). Involvement of JC virus-infected mononuclear cells from the bone mar-row and spleen in the pathogenesis of progressive mul-tifocal leukoencephalopathy. N Engl J Med 318: 301–305.
   PubMed Web of Science ®Google Scholar
• Houston S, Roberts N, et al (2001). Failure of cidofovir ther-apy in progressive multifocal leukoencephalopathy un-related to human immunodeficiency virus. Clin Infect Dis 32: 150–152.
   PubMed Web of Science ®Google Scholar
• Huang SS, Skolasky RL, et al (1998). Survival prolonga-tion in HIV-associated progressive multifocal leukoen-cephalopathy treated with alpha-interferon: an observa-tional study. J NeuroVirol 4: 324–332.
   PubMed Web of Science ®Google Scholar
• Jensen PN, Major EO (2001). A classification scheme for hu-man polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J NeuroVi-rol 7: 280–287.
   PubMed Web of Science ®Google Scholar
• Kepes JJ, Chou SM, et al (1975). Progressive multifocal leukoencephalopathy with 10-year survival in a patient with nontropical sprue. Report of a case with unusual light and electron microscopic features. Neurology 25: 1006–1012.
   Google Scholar
• Kerr D, Chang CF, et al (1994). Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene. J Virol 68: 7637–7643.
   PubMedGoogle Scholar
• Khalili K, Krynska B, et al (1999). Medulloblastomas and the human neurotropic polyomavirus JC virus. Lancet 353: 1152–1153.
   PubMed Web of Science ®Google Scholar
• Komagome R, Sawa H, et al (2002). Oligosaccharides as receptors for JC Virus. J Virol 76: 12992–13000.
   PubMed Web of Science ®Google Scholar
• Koralnik IJ, Du Pasquier RA, et al (2002). Association of prolonged survival in HLA-A2+ progressive multifo-cal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immuno1168: 499–504.
   Google Scholar
• Koralnik IJ, Du Pasquier RA, et al (2001). JC virus-specific cytotoxic T lymphocytes in individuals with progres-sive multifocal leukoencephalopathy. J Virol 75: 3483–3487.
   PubMed Web of Science ®Google Scholar
• Kunitake T, Kitamura T, et al (1995). Parent-to-child trans-mission is relatively common in the spread of the hu-man polyomavirus JC virus. J Clin Microbic)] 33: 1448–1451.
   PubMed Web of Science ®Google Scholar
• Levy RM, Ward S, et al (1997). Alternative delivery sys-tems for antiviral nucleosides and antisense oligonu-cleotides to the brain. J NeuroVirol 3\(Suppl 1): S74–575.
   Google Scholar
• Liu CK, Wei G, et al (1998). Infection of glial cells by the human polyomavirus JC is mediated by an N-linked gly-coprotein containing terminal alpha(2–6)-linked sialic acids. J Virol 72: 4643–4649.
   Google Scholar
• London WT, Houff SA, et al (1978). Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 201: 1246–1249.
   PubMed Web of Science ®Google Scholar
• Ma DD, Doan TL (1994). Antisense oligonucleotide thera-pies: are they the "magic bullets"? Ann Intern Med 120: 161–163.
   PubMed Web of Science ®Google Scholar
• Major EO (2001). Human Polyomavirus. In: Fields Virol-ogy, fourth edition, Knipe DM, Howley PM et al (eds.). pp. 2175–2196, Lippincott, Williams and Wilkins, New York.
   Google Scholar
• Major EO, Amemiya K, et al (1990). Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. J Neurosci Res 27: 461–471.
   PubMed Web of Science ®Google Scholar
• Major EO, Amemiya K, et al (1992). Pathogenesis and molecular biology of progressive multifocal leukoen-cephalopathy, the JC virus-induced demyelinating dis-ease of the human brain. Clin Microbiol Rev 5: 49–73.
   PubMed Web of Science ®Google Scholar
• Mamidi A, DeSimone JA, et al (2002). Central nervous sys-tem infections in individuals with HIV-1 infection. J NeuroVirol 8: 158–167.
   PubMed Web of Science ®Google Scholar
• Marra CM, Rajicic N, et al (2002). A pilot study of cido-fovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16: 1791–1797.
   PubMed Web of Science ®Google Scholar
• McGuire D, Barhite S, et al (1995). JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive mul-tifocal leukoencephalopathy. Ann Neurol 37: 395–399.
   PubMed Web of Science ®Google Scholar
• Miralles P, Berenguer J, et al (1998). Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12: 2467–2472.
   PubMed Web of Science ®Google Scholar
• Miralles P, Berenguer J, et al (2001). Inflammatory reac-tions in progressive multifocal leukoencephalopathy af-ter highly active antiretroviral therapy. AIDS 15: 1900–1902.
   Google Scholar
• Monaco MC, Jensen PN, et al (1998). Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 72: 9918–9923.
   PubMed Web of Science ®Google Scholar
• Monaco MC, Sabath BF, et al (2001). JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor. J Virol 75: 9687–9695.
   PubMed Web of Science ®Google Scholar
• Okada Y, Endo S, et al (2001). Distribution and function of JCV agnoprotein. J NeuroVirol 7: 302–306.
   PubMedGoogle Scholar
• Okada Y, Sawa H, et al (2002). Expression of JC virus agno-protein in progressive multifocal leukoencephalopathy brain. Acta Neuropathol (Bed) 104: 130–136.
   Google Scholar
• Padgett BL, Walker DL, et al (1971). Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1: 1257–1260.
   PubMed Web of Science ®Google Scholar
• Pfister LA, Letvin NL, et al (2001). JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Vi-rol 75: 5672–5676.
   Google Scholar
• Pho MT, Ashok A, et al (2000). JC virus enters human glial cells by clathrin-dependent receptor-mediated endocy-tosis. J Virol 74: 2288–2292.
   PubMed Web of Science ®Google Scholar
• Portilla J, Boix V, et al (2000). Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy. J Infect 41: 182–184.
   Google Scholar
• Power C, Gladden JG, et al (2000). AIDS- and non-AIDS-related PML association with distinct p53 polymor-phism. Neurology 54: 743–746.
   Google Scholar
• Raj GV, Khalili K (1994). Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines. Mol Cell Biol 14: 7770–7781.
   PubMedGoogle Scholar
• Raj GV, Khalili K (1995). Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virol-ogy 213: 283–291.
   PubMed Web of Science ®Google Scholar
• Ranganathan PN, Khalili K (1993). The transcriptional en-hancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res 21: 1959–1964.
   PubMedGoogle Scholar
• Razonable RR, Aksamit AJ, et al (2001). Cidofovir treat-ment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc 76: 1171–1175.
   PubMed Web of Science ®Google Scholar
• Ricciardiello L, Laghi L, et al (2000). JC virus DNA se-quences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology 119: 1228–1235.
   Web of Science ®Google Scholar
• Richardson EP Jr (1961). Progressive multifocal leukoen-cephalopathy. N Eng J Med 265: 815–823.
   Google Scholar
• Richardson EP, Webester HD (1983). Progressive multifocal leukoencephalopathy: Its pathologic features. In: Polyo-maviruses and human neurological diseases, Sever JL, Madden DL (eds.). p. 191, Alan R Liss, New York.
   Google Scholar
• Richardson-Burns SM, et al (2002). Progressive multi-focal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of pa-tients with and without AIDS. Arch Neurol 59: 1930–1936.
   Google Scholar
• Safak M, Barrucco R, et al (2001). Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J Virol 75: 1476–1486.
   Google Scholar
• Schneider EM, Dorries K (1993). High frequency of poly-omavirus infection in lymphoid cell preparations af-ter allogeneic bone marrow transplantation. Transplant Proc 25: 1271–1273.
   Google Scholar
• Staib C, Pesch J, et al (1996). p53 inhibits JC virus DNA replication in vivo and interacts with JC virus large T-antigen. Virology 219: 237–246.
   Google Scholar
• Sumner C, Shinohara T, et al (1996). Expression of multiple classes of the nuclear factor-1 family in the developing human brain: differential expression of two classes of NF-1 genes. J NeuroVirol 2: 87–100.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Zheng HY, et al (2002). Asian genotypes of JC Virus in Japanese-Americans suggest familial transmis-sion. J Virol 76: 10074–10078.
   Google Scholar
• Tantisiriwat W, Tebas P, et al (1999). Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 28: 1152–1154.
   PubMedGoogle Scholar
• Taoufik Y, Delfraissy JF, et al (2000). Highly active antiretro-viral therapy does not improve survival of patients with high JC virus load in the cerebrospinal fluid at progres-sive multifocal leukoencephalopathy diagnosis. AIDS 14: 758–759.
   PubMed Web of Science ®Google Scholar
• Tomatore C, Berger JR, et al (1992). Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 31: 454–462.
   PubMedGoogle Scholar
• Trowbridge PW, Frisque RJ (1995). Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. J NeuroVirol 1: 195–206.
   PubMed Web of Science ®Google Scholar
• Walker DL, Padgett BL, et al (1973). Human papovavirus (JC): induction of brain tumors in hamsters. Science 181: 674–676.
   PubMed Web of Science ®Google Scholar
• Weber T, Major EO (1997a). Progressive multifocal leukoen-cephalopathy: molecular biology, pathogenesis and clin-ical impact. Intervirology 40: 98–111.
   PubMed Web of Science ®Google Scholar
• Weber T, Trebst C, et al (1997b). Analysis of the systemic and intrathecal humoral immune response in progres-sive multifocal leukoencephalopathy. J Infect Dis 176: 250–254.
   PubMed Web of Science ®Google Scholar
• Weber T, Turner RW, et al (1994). Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid. AIDS 8: 49–57.
   PubMed Web of Science ®Google Scholar
• Wegner M, Drolet DW, et al (1993). Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoen-cephalopathy. Proc Nati Acad Sci USA 90: 4743–4747.
   PubMedGoogle Scholar
• Willoughby E, Price RW, et al (1980). Progressive multifo-cal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus. Neurology 30: 256–262.
   Google Scholar
• Yang B, Prayson RA (2000). Expression of Bax, Bc1-2, and P53 in progressive multifocal leukoencephalopathy. Mod Pathol 13: 1115–1120.
   Google Scholar
• Zambrano A, Kalantari M, et al (2002). Detection of human polyomaviruses and papillomaviruses in prostatic tis-sue reveals the prostate as a habitat for multiple viral infections. Prostate 53: 263–276.
   PubMedGoogle Scholar
• ZuRhein GM (1969). Association of papova-virions with a human demyelinating disease, progressive multi-focal leukoencephalopathy. Prog Med Virol 11:185–247.
   Google Scholar
• ZuRhein GM, Chou SM (1965). Particles resembling pa-povavirus in human cerebral demyelinating disease. Science 148: 1477–1479.
   PubMed Web of Science ®Google Scholar